Semirational bioengineering of AAV vectors with increased potency and specificity for systemic gene therapy of muscle disorders.

While the values did not reach statistical significance, we observed a trend toward better results with the AAVMYO3 vector over the AAV9 benchmark ( Fig. 9, E and F ).

also in 111,027 other papers